Researchers at Boston University School of Medicine said they’ve identified a key biomarker that may make it possible to diagnose chronic traumatic encephalopathy (CTE) in living patients. Previously, researchers have only been able to confirm a CTE diagnosis by studying the brains of deceased patients. “The findings in this study are the early steps toward identifying CTE during life,” Dr. Ann McKee, director of the CTE Center at Boston University, said in a statement. They were then able to differentiate between patients diagnosed with Alzheimer’s, CTE and ALS based on the levels of CCL11. AARON HERNANDEZ HAD 'SEVERE' CTE, LAWYER SAYSThe development comes months after McKee’s team discovered traces of CTE in 110 out of 111 brains of deceased former NFL players.

Source: Fox News September 27, 2017 13:41 UTC